| Patient demographics | ||||||||||||
| All patients | Patients with A1c ≥7.3% at baseline | |||||||||||
| QIIP (N=406) | Control (N=403) | QIIP (N=153) | Control (N=157) | |||||||||
| N | % | N | % | N | % | N | % | |||||
| Females, % | 406 | 46.6 | 403 | 50.9 | 153 | 45.8 | 157 | 49.0 | ||||
| Smoking status (% patients who smoke) | 333 | 21.3 | 294 | 23.5 | 128 | 17.2 | 113 | 21.2 | ||||
| N | Mean (SD) | N | Mean (SD) | N | Mean (SD) | N | Mean (SD) | |||||
| Age (years)* | 406 | 62.3 (11.4) | 403 | 62.9 (12.3) | 153 | 61.9 (11.4) | 157 | 60.5 (12.6) | ||||
| Age at diabetes diagnosis (years)† | 316 | 56.0 (12.4) | 324 | 55.9 (13.0) | 119 | 54.7 (11.9) | 120 | 50.4 (12.8) | ||||
| N | Mean (SD) | Median | N | Mean (SD) | Median | N | Mean (SD) | Median | N | Mean (SD) | Median | |
| Duration of diabetes (years)‡ | 316 | 6.2 (6.3) | 4.4 | 324 | 6.0 (5.6) | 4.4 | 119 | 6.9 (5.9) | 5.1 | 120 | 8.4 (6.8) | 7.0 |
*Age calculated from year of birth to start of baseline.
†Age at diabetes diagnosis for patients with A1C ≥7.3% at baseline, significant p value, p=0.01.
‡Duration of type 2 diabetes calculated from year of diagnosis to start of baseline; no significant differences.
QIIP, Quality Improvement and Innovation Partnership.